OUR CORE SERVICES
COMMERCIALIZATION READINESS ASSESSMENT AND SCORING OF INNOVATIONS AND EARLY-STAGE COMPANIES
We assess and benchmark commercial readiness of individual technologies and early-stage companies using an ICANVAS® methodology to obtain quantitative and qualitative information that empowers your business decision.
SPOT & IDENTIFY
An opportunity is sourced and its key elements are identified. At earlystage, we are typically focused on eight-ten key elements including team, technology, resources, intellectual property, manufacturing, business strategy, market fit, manufacturing, and regulatory considerations.
ISOLATE & PRIORITIZE
The opportunity’s key elements are isolated, prioritized and the initial screening is performed. This includes inventors’ interviews and secondary research, including publications analysis, market research, and competitive intelligence.
ASSESS & EVALUATE
Each of the key elements is assessed and evaluated by primary research conducted by the earlystage team. This includes potential risks and exits verification, confirmation of invention claims, business, and financial modeling, in-person interview of experts, stakeholders, payers, and end-users.
CONVERGE & SCORE
Earlystage team converges all key elements into an innovation commercial readiness canvas (ICANVAS®) and prepares a detailed report for a client with a final commercialization readiness score (CRS™).
OUR PRIMARY PRACTICE AREAS
Pharma & Biotech
WE LITERALLY WROTE A BOOK ON ASSESSMENT!
Over 90% of all startups fail... Here is a book to help you understand the risks and opportunities of your potential investment.
Innovation Canvas - A Systematic Assessment Methodology for the Commercial Readiness of Early-Stage Companies
by Zagit Z. Gaymalov, Ph.D.
Download the book for free, just fill the form below!
(do not worry, we hate spam too)
OUR ADDITIONAL PRACTICE AREAS
OUR ADDITIONAL SERVICES
We create custom-tailored technology landscape maps using our RECOPE® methodology to obtain a structured external perspective that helps you outmaneuver your competition.
PATHS TO COMMERCIALIZATION
We developing pathways to commercialization by conceptually reverse product planning approach - RECOPE™ focused on the meaningful integration of technological innovations into a pipeline and accelerations to the market.
Schedule a short call with Z to discuss your project!
Zagit Z. Gaymalov, PhD.
With extensive experience in commercialization of health innovations, technology transfer, licensing and new product development, Z led projects for multi-campus public universities and helped develop innovation-focused activities for clients in the North American and the Middle East. He championed technology scouting and partnership development activities, identified innovation assets and constructed economic development strategies. He invented a commercialization assessment methodology - ICANVAS® and co-invented conceptually reverse product engineering methodology - RECOPE™.
Z earned his B.S. in Molecular Biology and Genetics from Middle East Technical University and his Ph.D. in Pharmaceutical Sciences from the University of Nebraska Medical Center (UNMC). He completed his postdoctoral training in translational medicine at UNMC and the University of North Carolina at Chapel Hill. His American Heart Association pre-doctoral fellowship led to the creation of therapy for the treatment of hind-limb ischemia.